AI assistant
MetaVia Inc. — Director's Dealing 2021
Jan 5, 2021
34919_dirs_2021-01-05_b80cfa85-0a0c-498c-b553-3c122252f53a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2020-12-31
Reporting Person: Bakshi Akash (Director, SVP and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Common Stock | A | 29013 | — | Acquired | 29013 | Direct |
| 2020-12-31 | Common Stock | A | 855059 | — | Acquired | 884072 | Indirect |
Footnotes
F1: Received in exchange for shares of ANA Therapeutics, Inc. ("ANA") common stock in connection with the acquisition of ANA by the Company.
F2: The reportable securities are owned directly by YourChoice Holdings, LLC ("YourChoice"). Mr. Bakshi is the CEO and a director of YourChoice. Mr. Bakshi disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.